Yogesh Jethava

1.7k total citations
50 papers, 423 citations indexed

About

Yogesh Jethava is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Yogesh Jethava has authored 50 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 23 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Yogesh Jethava's work include Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (12 papers) and Acute Myeloid Leukemia Research (7 papers). Yogesh Jethava is often cited by papers focused on Multiple Myeloma Research and Treatments (32 papers), Protein Degradation and Inhibitors (12 papers) and Acute Myeloid Leukemia Research (7 papers). Yogesh Jethava collaborates with scholars based in United States, Canada and China. Yogesh Jethava's co-authors include Guido Tricot, Fenghuang Zhan, Praveen Vikas, Nicholas Borcherding, Ivana Frech, Hua Bai, Laura F. Hutchins, Bipin N. Savani, Xin Zhan and Simona Sica and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yogesh Jethava

42 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yogesh Jethava United States 10 249 206 151 53 39 50 423
Danai Dima United States 12 180 0.7× 170 0.8× 233 1.5× 40 0.8× 41 1.1× 69 409
Hyewon Lee South Korea 12 220 0.9× 127 0.6× 150 1.0× 88 1.7× 46 1.2× 38 424
Giambattista Bertani Italy 8 302 1.2× 188 0.9× 70 0.5× 103 1.9× 47 1.2× 20 460
Jagoda Jasielec United States 13 390 1.6× 339 1.6× 252 1.7× 44 0.8× 46 1.2× 40 553
Dennis Talbot United Kingdom 5 135 0.5× 191 0.9× 120 0.8× 68 1.3× 41 1.1× 6 595
Nour Moukalled Lebanon 11 193 0.8× 87 0.4× 192 1.3× 61 1.2× 67 1.7× 43 406
Samah Nassereddine United States 9 199 0.8× 118 0.6× 78 0.5× 66 1.2× 74 1.9× 20 375
Dawn Colburn United States 10 135 0.5× 252 1.2× 160 1.1× 75 1.4× 38 1.0× 20 524
Maciej Kaźmierczak Poland 13 194 0.8× 161 0.8× 90 0.6× 93 1.8× 63 1.6× 41 475
Thomas G Martin United States 10 369 1.5× 318 1.5× 263 1.7× 36 0.7× 23 0.6× 19 504

Countries citing papers authored by Yogesh Jethava

Since Specialization
Citations

This map shows the geographic impact of Yogesh Jethava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yogesh Jethava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yogesh Jethava more than expected).

Fields of papers citing papers by Yogesh Jethava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yogesh Jethava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yogesh Jethava. The network helps show where Yogesh Jethava may publish in the future.

Co-authorship network of co-authors of Yogesh Jethava

This figure shows the co-authorship network connecting the top 25 collaborators of Yogesh Jethava. A scholar is included among the top collaborators of Yogesh Jethava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yogesh Jethava. Yogesh Jethava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnulf, Bertrand, Tessa Kerre, Mounzer Agha, et al.. (2024). Efficacy and safety of ciltacabtagene autoleucel ± lenalidomide maintenance in newly diagnosed multiple myeloma with suboptimal response to frontline autologous stem cell transplant: CARTITUDE-2 cohort D.. Journal of Clinical Oncology. 42(16_suppl). 7505–7505. 2 indexed citations
2.
Nadiminti, Kalyan, Mehrdad Hefazi, Yogesh Jethava, et al.. (2021). A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction. Blood Cancer Journal. 11(11). 183–183. 2 indexed citations
3.
Ayyappan, Sabarish, David S. Dickens, Yogesh Jethava, et al.. (2021). Wearable Monitors Facilitate Exercise in Adult and Pediatric Stem Cell Transplant. Exercise and Sport Sciences Reviews. 49(3). 205–212. 2 indexed citations
4.
Borcherding, Nicholas, Yogesh Jethava, & Praveen Vikas. (2020). Repurposing Anti-Cancer Drugs for COVID-19 Treatment. SHILAP Revista de lepidopterología. 4 indexed citations
5.
Borcherding, Nicholas, Yogesh Jethava, & Praveen Vikas. (2020). <p>Repurposing Anti-Cancer Drugs for COVID-19 Treatment</p>. Drug Design Development and Therapy. Volume 14. 5045–5058. 27 indexed citations
6.
7.
Zhu, Yuqi, Ye Yang, Yogesh Jethava, et al.. (2019). Targeting NEK2 Induces Cellular Senescence in B-Cell Malignancies through p53-Independent Signaling Pathways. Blood. 134(Supplement_1). 3102–3102. 2 indexed citations
8.
Li, Can, Xuelian Tan, Yogesh Jethava, et al.. (2019). Altered Iron Metabolism Is a New Targetable Hallmark for Multiple Myeloma. Blood. 134(Supplement_1). 3059–3059. 2 indexed citations
9.
10.
Mott, Sarah L., et al.. (2018). Bloodless tandem autologous transplant in Jehovah’s Witness patients. Bone Marrow Transplantation. 53(11). 1428–1433. 5 indexed citations
11.
Hao, Mu, Hua Bai, Zhimin Gu, et al.. (2018). Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. Journal of Clinical Investigation. 128(7). 2877–2893. 70 indexed citations
12.
13.
14.
Hao, Mu, Hua Bai, Zhimin Gu, et al.. (2017). The Interaction of NEK2 with USP7 Causes Resistance to Proteasome Inhibitor in Multiple Myeloma. Blood. 130. 593–593. 1 indexed citations
15.
16.
Jethava, Yogesh, Guru Subramanian Guru Murthy, & Mehdi Hamadani. (2017). Relapse of Hodgkin lymphoma after autologous transplantation. Hematology/Oncology and Stem Cell Therapy. 10(2). 47–56. 6 indexed citations
17.
Jethava, Yogesh, Simona Sica, Bipin N. Savani, et al.. (2017). Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia. Bone Marrow Transplantation. 52(11). 1504–1511. 47 indexed citations
18.
Jethava, Yogesh & Frits van Rhee. (2016). Transplantation for Multiple Myeloma. Cancer treatment and research. 169. 227–250. 2 indexed citations
19.
Khan, Rashid, Madhav V. Dhodapkar, Adam Rosenthal, et al.. (2015). Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120). Haematologica. 100(9). 1214–1221. 34 indexed citations
20.
Zangari, Maurizio, Joshua Epstein, Shmuel Yaccoby, et al.. (2014). Higher Expressions of PTH Receptor Type 1 and/or 2 in Bone Marrow Is Associated to Longer Survival in Newly Diagnosed Myeloma Patients Enrolled in Total Therapy 3. Blood. 124(21). 3409–3409. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danai Dima Breakdown of academic impact, for papers by Hyewon Lee Breakdown of academic impact, for papers by Giambattista Bertani Breakdown of academic impact, for papers by Jagoda Jasielec Breakdown of academic impact, for papers by Dennis Talbot Breakdown of academic impact, for papers by Nour Moukalled Breakdown of academic impact, for papers by Samah Nassereddine Breakdown of academic impact, for papers by Dawn Colburn Breakdown of academic impact, for papers by Maciej Kaźmierczak Breakdown of academic impact, for papers by Thomas G Martin
Rankless by CCL
2026